About Conference

Heart Congress 2024 extends a warm invitation to all individuals intrigued by the intricate functionalities and rhythms of the heart to attend the “2nd American Congress on Heart and Cardiovascular Diseases 2024 “taking place from December 11-12, 2024. Originally slated Los Angeles, USA this event will now be held as a physical gathering.

Heart Congress 2024 will bring together eminent professors, scientists, researchers, students and cardiologists to delve into topics such as methodologies for heart disease remediation, electrocardiography, heart failure, pediatric cardiology, and associated health disorders. The conference aims to provide invaluable insights into the challenges impacting the diagnosis, prognosis, and treatment of cardiovascular diseases.

Theme : Cardiovascular Health Equity: Bridging Gaps, Building Bridges

Key Highlights of Euro Heart Congress 2024 in Paris, France:

Three days of robust scientific exchange

Over 200 abstracts submitted

More than 30 scientific sessions planned

Participation of over 80 international expert faculty members

Attendance by over 100 healthcare professionals

This international conference offers a unique opportunity for clinicians, scientists, doctors, and researchers worldwide to come together, exchange scientific ideas, and stay abreast of the latest advances in cardiology and healthcare.

Why Attend?

Attendees can expect to engage with a diverse global community focused on exploring recent developments and solutions in cardiology and healthcare. Renowned keynote and plenary speakers, alongside the latest advancements in the field, signify the significance of this conference. Participation in this event fosters networking opportunities, collaboration, and knowledge-sharing among experts, researchers, and academicians.

Conference Opportunities:

• For Researchers and Faculty Members:
• Speaker Presentations
• Poster Displays
• Symposium Hosting (Team of 4-5 members)
• Workshop Organization
• For Universities, Associations & Societies:
• Book Launch Events
• Networking Opportunities
• Audience Participation
• For Product Manufacturers:
• Exhibitr and Vendor Booths
• Sponsorship Opportunities
• Product Launches
• Workshop Organization
• Scientific Partnering
• Marketing and Networking with Clients

Session and Tracks 

Track 1: Heart Disease & Failure

Heart disease encompasses disorders affecting the heart, including blood vessel diseases like coronary artery disease, heart rhythm problems (arrhythmias), and congenital heart defects. Heart failure occurs when the heart can’t pump enough blood to meet the body’s needs, but it doesn’t mean the heart has stopped working. Conditions include coronary artery disease, congenital heart defects, and cardiomyopathy.

• Angiology
• Atrial Fibrillation
• Atrial Myxoma
• Unstable Angina
• Rehabilitation
• Transient Ischemic Attack
• Atherosclerosis
• Cardiomyopathy
• Cardiac Stroke

Track 2: Cardiac and Cardiovascular Research

This track focuses on raising awareness about heart disease risk factors and providing comprehensive cardiovascular services. It emphasizes prevention, detection, management, and treatment of cardiovascular diseases through postgraduate education and scientific work.

• Cardiac Electrophysiology
• Peripheral Arterial Disease
• 3D Cardiac Cell Modeling
• Genetic Basis for Inherited Cardiovascular Disease

Track 3: Diabetes, Obesity & Stroke

Obesity increases the risk of heart disease and stroke, often due to lifestyle choices like lack of exercise and poor diet. Diabetes and pre-diabetes also elevate cardiovascular risk. This track emphasizes managing blood glucose, hypertension, and blood cholesterol to lower the risk of heart disease and stroke.

• Diabetes Mellitus and Stroke
• Abdominal Obesity
• Vascular Dementia
• Abnormal Cholesterol and High Triglycerides
• Hemorrhagic Strokes (Bleeds)

Track 4: Pediatric Cardiology

This track deals with diagnosing and managing congenital heart defects and other cardiac conditions in infants, children, and adolescents. It addresses inflammatory heart diseases, such as myocarditis, and conditions like Kawasaki disease.

• Cardiac Malformation
• Congenital Abnormalities
• Hypplastic Left Heart Syndromes
• Auditory Stimulation Therapy
• Myocarditis

Track 5: Cardiovascular Disease

Covering a range of heart and blood vessel disorders, including coronary artery diseases, stroke, heart failure, and congenital heart defects. It highlights the importance of managing risk factors like hypertension and obesity.

• Pericarditis
• Valvular Heart Diseases
• Coronary Artery Diseases
• Rheumatic Heart Diseases
• Congenital Heart Defect
• Venous Thrombosis

Track 6: Women’s Cardiology

Focuses on cardiovascular health in women, addressing specific issues like pregnancy-related disorders and the persistence of weight gain after pregnancy. It aims to bridge the gap in sex-specific data collection and its translation into clinical practice.

• Pregnancy-related disorders and CVD risk association
• Persistence of weight gain after pregnancy
• Radiation and chemotherapy for breast cancer
• ASA in women with diabetes mellitus
• Ischemic heart disease in women
• Acute coronary syndromes in women

Track 7: Nuclear Cardiology

Utilizes nuclear imaging techniques for non-invasive cardiovascular disease evaluation. It involves injecting radiotracers into the bloodstream to create images of the heart, aiding in diagnosis and treatment planning.

• Modern practices in cardiovascular therapy
• Vasodilators
• Percutaneous Coronary Intervention (PCI)
• Heart Transplant
• Application of cardiac progenitor cells

Track 8: Angiography & Intervention

Focuses on visualizing blood vessels through angiography and catheter-based treatments for structural heart diseases. It emphasizes minimally invasive approaches to avoid scarring and long recovery periods.

• Microangiography
• Percutaneous valve replacement
• Neuro-Vascular Angiography
• Catheter
• Stent

Track 9: Molecular Cardiology

Studies genetic heart disorders and aims to reduce human disease through integrating basic science research and clinical cardiology. It explores the link between genetics, environmental factors, and cardiovascular diseases.

• Gene Analysis in the Diseased Heart
• Investigate the stem cell niche in tissue regeneration.
• Medical genetics
• Integrins and chemokine receptors in heart physiology & cardiovascular disease

Track 10: Cardio-Oncology

Addresses heart conditions in cancer patients, focusing on potential risks associated with cancer treatment. It involves close monitoring of heart health during treatment and the management of chemotherapy-related cardiac dysfunctions.

• Chemotherapy-related cardiac dysfunctions
• Platinum-based chemotherapy agents
• Cardio-oncology programs
• Novel targeted therapies
• Radiation-Induced Heart Disease

Track 11: Cardiologists

Specializes in heart and blood vessel disorders, providing diagnosis, treatment, and prevention services. It encompasses various specialties like general clinical cardiology, pediatric cardiology, and preventive cardiology.

• General clinical cardiologists
• Pediatric cardiologists
• Cardiovascular Anesthesiology
• Cardiovascular Pathology Research
• Preventive cardiologists

Track 12: Vascular Biology

Studies vascular function, structure, growth, and development to improve blood flow and organ perfusion. It focuses on identifying new therapeutic targets and developing novel treatment approaches.

• Angiogenic gene therapy
• Oxidative stress and vascular biology
• Vascular Surgery
• Vascular medicine
• Vascular Imaging and Diagnostic Testing
• Molecular Biophysics and Structural Biology
• Stem Cell Biology

Track 13: Hypertension

Addresses persistently elevated blood pressure and its implications, including risks of heart attack, stroke, and other complications. It emphasizes screening, management, and treatment of hypertension.

• Pulmonary hypertension
• Perioperative management in hypertension
• Erectile dysfunction
• Systolic/Diastolic malfunction
• Indications and contraindications for antihypertensive drugs
• Hypertension in acute stroke

Track 14: Cardiac Nursing

Specializes in caring for patients with cardiovascular diseases, providing postoperative care, stress test evaluations, and cardiac monitoring. It encompasses various environments like coronary care units, intensive care units, and cardiac rehabilitation centers.

• Stress test evaluations
• Hemodynamic Monitoring
• Monitoring cardiac and vascular readings
• Intensive hemodialysis
• Carig for Heart Transplant Patients

Track 15: Heart Regeneration

Focuses on repairing or replacing damaged heart tissue using techniques like stem cell therapy and tissue engineering. It aims to restore heart function by harnessing the body’s natural regenerative capacity.

• Transdifferentiation During Heart Regeneration
• Cardiac Remodeling
• Cardiac-Derived Stem Cells
• Tissue Engineering-Concepts for Generation of Cardiac Tissue
• Biomimetic Heart Valve Replacement

Track 16: Cardiac Pharmacology

Deals with medication for cardiac diseases, including categories like cardiac glycosides, anti-coagulants, and anti-hypertensive agents. It emphasizes the development of new drugs and managing drug-induced cardiac toxicity.

• Drug-Induced Cardiac Toxicity
• Novel Anti-Inflammatory Therapies for Atherosclerosis
• Development of Novel Anti-Ischemic Agents
• Beta Blockers Blocking
• Cardiac Glycoside

Track 17: Cardiology – Future Medicine

Explores advancements and innovations in cardiology, including personalized medicine, novel treatment approaches, and the role of technology. It aims to improve clinical practice and patient outcomes.

• Development of pacemaking and Cardiac Conduction System Lineages
• Rol of platelets and antiplatelet therapy in cardiovascular disease
• Molecular Targets of Antihypertensive Drug Therapy
• Real-world Evidence and Outcomes Research
• ‘Personalized Medicine’ In Cardiology

Track 18: Case Reports on Cardiology

Highlights case studies to advance treatment strategies and improve understanding of cardiac disorders. It emphasizes networking and knowledge sharing among professionals and academicians.

• Aortic Diseases
• Infective Endocarditis
• Disorders due to Coronary Circulation
• Myocardium and Pericardium
• How to Counter Coronary Artery Disease

Track 19: Heart Diagnosis

Focuses on various diagnostic methods for heart diseases, including imaging techniques and cardiac surgeries. It emphasizes the importance of early detection and medical care for managing heart conditions.

• Electrocardiogram & Echocardiography
• Holter Monitoring
• Cardiac Computerized Tomography (CT) scan
• Cardiac Magnetic Resonance Imaging (MRI)
• Chest X-ray

Track 20: Heart Devices

Involves electronic devices for assisting cardiac circulation, such as pacemakers, defibrillators, and biosensors. It explores advancements in wireless cardiac monitoring and individualized medicine.

• Implantable Cardioverter-Defibrillator (ICD)
• Cardiac Resynchronization Therapy (CRT)
• Left Ventricular Assist Device (LVAD)
• The Heart Ware’s Ventricular Assist System
• The Levacor Heart Pump

Track 21: Cardiac Surgery

Addresses surgical interventions for heart and blood vessel disorders, including coronary artery bypass grafting and valve replacement. It emphasizes minimally invasive approaches and heart transplantation.

• Minimally Invasive Coronary Artery Bypass Surgery
• Valve-Sparing Aortic Root Replacement
• Open-heart surgery
• Transmyocardial Laser Revascularization
• Off-Pump Heart Surgery

Market Analysis

The primary objective of the 2nd American Congress on Heart and Cardiovascular Diseases 2024 is to ensure the provision of clinically appropriate and cost-effective care for individuals suffering from heart disease. This initiative is prompted predominantly by conditions such as ischemic heart disease, stroke, dyslipidemia, thrombosis, atherosclerosis, coronary artery diseases, peripheral artery disease, hypertension, and others. The leading causes of these disorders include unhealthy dietary habits, obesity, smoking, high cholesterol, sedentary lifestyle, excessive alcohol consumption, and poor overall lifestyle choices. With cardiovascular diseases responsible for approximately 15 million deaths globally each year, and constituting a significant cause of mortality in about 50% of adults, there is an urgent need for a dedicated platform for the advancement, implementation, and dissemination of knowledge concerning Cardiovascular Medicine and its associated fields through events like National/International symposiums, Conferences, and Workshops.

Aetiology, Clinical Characteristics, and Therapy:

Heart failure’s etiology includes hypertension (45%), cardiomyopathies (28%), rheumatic heart disease (12%), ischemic heart disease (9%), and other factors such as probable tuberculosis or HIV-related cardiomyopathies, endomyocardial fibrosis, and obstructive lung disease (6%). Among cardiomyopathies, idiopathic dilated cardiomyopathy was the most prevalent (81%), followed by postpartum cardiomyopathy (15%), while hypertrophic and restrictive cardiomyopathies were less common (5%). Rheumatic mitral disease with regurgitation was the most prevalent valvular lesion (81%), followed by mitral stenosis (15%) and aortic regurgitation (3%).

Importance and Scope:

The World Cardiology Meeting serves as an ideal platform for scientists, cardiologists, oncologists, electrophysiologists, surgeons, nurses, research scholars, and students to exchange knowledge in the field of Cardiology and Cardiac Surgery. This international event aims to explore alternatives to invasive imaging techniques for diagnosing heart diseases and heart failure in both adults and children.

Cardiology Market Growth:

North America dominates the heart diagnostics market, accounting for approximately 47% of revenue share in 2024, followed by Europe (38%) and Asia (15%).

Statistics of Physicians, Researchers, and Academicians in Cardiology Research:

Key contributors in the field of Cardiology include Directors, Heads, Deans, Professors, Scientists, Researchers, Doctors, Students, and Writers in the Pediatric Cardiology Department. Additionally, individuals associated with related companies, associations, laboratories, and other organizations play a significant role in advancing Cardiology research.

Therapeutic Approaches:

The primary goal of heart failure therapy is to impede disease progression through pharmacological and device-based interventions. Efforts are directed towards developing device-based therapies that enhance cardiac reserve and optimize pump function to meet metabolic demands. Timely identification of subtle pathophysiologic changes associated with heart failure could potentially lead to preventive measures, highlighting the potential role of device-based methods in identifying such changes.